Edition:
United States

People: Thomson Reuters Corp (TRI.N)

TRI.N on New York Stock Exchange

65.72USD
23 Aug 2019
Change (% chg)

$-1.61 (-2.39%)
Prev Close
$67.33
Open
$67.05
Day's High
$67.60
Day's Low
$65.57
Volume
107,314
Avg. Vol
130,139
52-wk High
$70.93
52-wk Low
$46.47

Peck, Kristin 

Ms. Kristin C. Peck is an Independent Director of the Company. Kristin Peck is Executive Vice President and Group President, U.S. Operations, Business Development and Strategy at Zoetis, a NYSE-listed global leader in the discovery, development, manufacture and commercialization of animal health medicines and vaccines that was spun off by Pfizer in 2013. From October 2012 through April 2015, she served as Executive Vice President and Group President of Zoetis. Ms. Peck joined Pfizer in 2004 and held various positions, including Executive Vice President, Worldwide Business Development and Innovation; Senior Vice President, Worldwide Business Development, Strategy and Innovation; Vice President, Strategic Planning; Chief of Staff to the Vice Chairman; and Senior Director, Strategic Planning. She also served as a member of Pfizer’s Executive Leadership Team. Prior to joining Pfizer, Ms. Peck was a Principal at Boston Consulting Group. She holds a Bachelor’s degree from Georgetown University and a Master of Business Administration from Columbia Business School.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Awards, USD 200,000
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 200,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

David Thomson

600,000

James Smith

14,485,100

David Binet

350,000

Stephane Bello

4,903,470

Michael Friedenberg

5,660,360

Piotr Marczewski

--
As Of  30 Dec 2018